89bio (NASDAQ:ETNB) Stock Quotes, Forecast and News Summary

Q: What sector and industry does 89bio (ETNB) operate in?

89bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

89bio Stock (NASDAQ: ETNB) stock price, news, charts, stock research, profile.

Open	$8.42
Close	$8.76
Volume / Avg.	493.69K / 682.90K
Day Range	$8.30 - $8.91
52 Wk Range	7.00 - 16.63
Market Cap	$1.01B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	5.72%
Days to Cover	12.59

Recent News

What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?

Madrigal Pharmaceuticals and Sagimet Biosciences shares fall following Eli Lilly's presentation at the EASL Liver Congress 2024. Phase 2 tirzepatide trial shows promising results for MASH treatment. Further trials needed to confirm efficacy and safety.

Vandana Singh

Over $20M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying

Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades.

Avi Kapoor

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its SEAL01 Bitcoin mining chip and amid overall strength in the price of Bitcoin.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Aug

Sep

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$8.42
Close	$8.76
Volume / Avg.	493.69K / 682.90K
Day Range	$8.30 - $8.91
52 Wk Range	7.00 - 16.63
Market Cap	$1.01B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	5.72%
Days to Cover	12.59

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy 89bio (ETNB) stock?

You can purchase shares of 89bio (NASDAQ:ETNB) through any online brokerage.

View our list of the best stock brokerages

Who are 89bio (ETNB) competitors?

Other companies in 89bio’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Upstream Bio (NASDAQ:UPB) and Syndax Pharmaceuticals (NASDAQ:SNDX).

What is the forecast, or price target, for 89bio (ETNB) stock?

89bio has a consensus price target of $29.20.

What is the current price for 89bio (ETNB)?

The stock price for 89bio (NASDAQ: ETNB) is $8.6 last updated November 22, 2024 at 5:28 PM EST.

Does 89bio (ETNB) pay a dividend?

There are no upcoming dividends for 89bio.

When is 89bio (NASDAQ:ETNB) reporting earnings?

89bio’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is 89bio (ETNB) going to split?

There is no upcoming split for 89bio.

What sector and industry does 89bio (ETNB) operate in?

89bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

89bio

89bio (ETNB) Forecast